KNSA
Price
$27.70
Change
+$0.26 (+0.95%)
Updated
Jul 3, 12:40 PM (EDT)
Capitalization
2B
26 days until earnings call
KNTPF
Price
$0.18
Change
-$0.03 (-14.29%)
Updated
Apr 7 closing price
Capitalization
82.91M
Interact to see
Advertisement

KNSA vs KNTPF

Header iconKNSA vs KNTPF Comparison
Open Charts KNSA vs KNTPFBanner chart's image
Kiniksa Pharmaceuticals International
Price$27.70
Change+$0.26 (+0.95%)
Volume$356
Capitalization2B
KINTOR PHARMACEUTICAL
Price$0.18
Change-$0.03 (-14.29%)
Volume$750
Capitalization82.91M
KNSA vs KNTPF Comparison Chart in %
Loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNSA vs. KNTPF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNSA is a Hold and KNTPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (KNSA: $27.44 vs. KNTPF: $0.18)
Brand notoriety: KNSA and KNTPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNSA: 110% vs. KNTPF: 100%
Market capitalization -- KNSA: $2B vs. KNTPF: $82.91M
KNSA [@Biotechnology] is valued at $2B. KNTPF’s [@Biotechnology] market capitalization is $82.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNSA’s FA Score shows that 1 FA rating(s) are green whileKNTPF’s FA Score has 0 green FA rating(s).

  • KNSA’s FA Score: 1 green, 4 red.
  • KNTPF’s FA Score: 0 green, 5 red.
According to our system of comparison, KNSA is a better buy in the long-term than KNTPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNSA’s TA Score shows that 3 TA indicator(s) are bullish while KNTPF’s TA Score has 2 bullish TA indicator(s).

  • KNSA’s TA Score: 3 bullish, 5 bearish.
  • KNTPF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, KNTPF is a better buy in the short-term than KNSA.

Price Growth

KNSA (@Biotechnology) experienced а -3.31% price change this week, while KNTPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +33.07%, and the average quarterly price growth was +3.79%.

Reported Earning Dates

KNSA is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($2B) has a higher market cap than KNTPF($82.9M). KNSA YTD gains are higher at: 38.726 vs. KNTPF (10.875).
KNSAKNTPFKNSA / KNTPF
Capitalization2B82.9M2,415%
EBITDA-14.23MN/A-
Gain YTD38.72610.875356%
P/E Ratio164.54N/A-
Revenue481MN/A-
Total Cash268MN/A-
Total Debt9.92MN/A-
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KNSAKNTPF
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
33%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAIDX56.40N/A
N/A
Fidelity Advisor International Discv A
MEIFX13.85N/A
N/A
Meridian Hedged Equity Legacy
WPSZX56.14N/A
N/A
AB Concentrated Growth Z
NMUEX10.90N/A
N/A
Neuberger Berman Multi-Cap Opp E
MBCNX16.57N/A
N/A
MassMutual Blue Chip Growth R3

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with ABVC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then ABVC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.73%
ABVC - KNSA
40%
Loosely correlated
+28.10%
COYA - KNSA
40%
Loosely correlated
+1.54%
BEAM - KNSA
36%
Loosely correlated
+13.46%
AMRN - KNSA
36%
Loosely correlated
-0.95%
CPRX - KNSA
35%
Loosely correlated
+1.23%
More

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
-3.99%
KNSA - KNTPF
20%
Poorly correlated
+0.73%
UNCY - KNTPF
20%
Poorly correlated
-2.94%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
+2.80%
More